Form D · Pharmaceuticals

SpineThera, Inc.

Plymouth, MN · CIK 0001608110

Offering snapshot reported Dec 10, 2021 · SEC filing

Reported sold
$1.22M
Offering amount: $4M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 30, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 10, 2021Initial$1,215,000No comparison12SEC filing
Nov 13, 2018Initial$2,000,001No comparison1SEC filing
Aug 28, 2018Initial$2,965,000No comparison25SEC filing
Feb 20, 2018Initial$2,007,500No comparison14SEC filing
Sep 9, 2015Initial$400,025No comparison6SEC filing
Aug 5, 2015Initial$2,360,000No comparison17SEC filing
May 20, 2014Initial$585,070No comparison5SEC filing

Offering details

Securities
Equity, Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-424520

Source: Form D, filed Dec 10, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Foster Director
Jerome Jerome Director
Wayne Kelly Director
Jeffrey Missling Director, Executive
Jeff Missling Director, Executive
John Renger Director
David Wood Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
15600 Medina Road Suite 247
Plymouth, MN, 55447